BOSTON – Dec. 13, 2022 –Roman Fayerberg, Intellectual Property (IP) & Technology shareholder in global law firm Greenberg Traurig, LLP’s Boston office, is speaking on the Boston Bar Association (BBA) panel, “IP Considerations for Medical Device Companies,” Dec. 13. Speakers will discuss the intersectionality between Food and Drug Administration regulation and patent law, patent filing strategies for emerging medical technologies, and 510k submissions.
Fayerberg is a registered patent attorney with broad experience helping clients strategically protect and leverage their innovations globally. He works with clients to develop and manage worldwide patent portfolios and counsels clients regarding freedom to operate, patent landscape, and patent infringement and validity matters. Fayerberg also conducts and defends patent due diligence investigations in connection with venture capital investments, mergers and acquisitions, and licensing opportunities.
Fayerberg has represented clients ranging from startups to global companies in a variety of technical areas, including medical devices, robotics, diagnostic and imaging systems, microfluidic devices, and biotechnology. He understands the legal goals of each of his clients and develops and executes patent strategies that meet such goals.
A frequent speaker and author on topics related to patent law, Fayerberg has been recognized in IAM magazine’s IAM Patent 1000: The World’s Leading Patent Professionals. He previously served as a co-chair of the Boston Bar Association’s IP Section and as a co-chair of the Medical Device, Diagnostics & Digital Health Committee of the Massachusetts Biotechnology Council (MassBio).